transcription, транскрипция: [ [pol-ee-GLOO-tuh-mayt kamp-toh-THEEK-in] ]
A form of the anticancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It belongs to the family of drugs called DNA topoisomerase inhibitors. Also called CT-2106.